Editorial: Interferon-Targeted Therapy for Systemic Lupus Erythematosus: Are the Trials on Target?
- PMID: 27860434
- DOI: 10.1002/art.39985
Editorial: Interferon-Targeted Therapy for Systemic Lupus Erythematosus: Are the Trials on Target?
Comment on
-
Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus.Arthritis Rheumatol. 2017 Feb;69(2):376-386. doi: 10.1002/art.39962. Arthritis Rheumatol. 2017. PMID: 28130918 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
